For a long time, clinicians have searched for successful treatments for severe mood disorders. Now indicates this novel drug therapy, provided typically intravenously , IV copyright therapy can offer real opportunity for people who haven’t responded from traditional therapies. While primarily considered a developing treatment , early findings are